Vasista Vittal's Form 4 filing
REGENXBIO Inc. (RGNX) · filed Aug 8, 2022
- Accession no.
- 0001562180-22-005938
- Filed
- Aug 8, 2022
- Trade date
- Aug 4-5, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $622.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vasista VittalCIK 0001652827 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 | Common Stock | SSaleDisposed | −400 | $35.00 | −$14,000 | 154,840 | Direct | |
| Aug 5, 2022 | Common Stock | SSaleDisposed | −17,280 | $35.19 | −$608,083.2 | 137,560 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.